Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2017-08-16 2017-08-16
Drug Identification Number 00603279 00603279
Brand name APO AMPI CAPSULES 250MG APO AMPI CAPSULES 250MG
Common or Proper name AMPICILLIN AMPICILLIN
Company Name APOTEX INC APOTEX INC
Ingredients AMPICILLIN AMPICILLIN
Strength(s) 250MG 250MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL & 1000 BTL 100 BTL & 1000 BTL
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10 2017-03-10
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments